Evaluation of the pattern of psychiatric medications used by long‐term cancer survivors is an inadequate surrogate marker with which to gauge survivors' emotional health. Specialty‐level assessment and treatment are important for precise differential diagnosis and treatment when central nervous system disease recurrence can mimic psychiatric symptoms.